Spotlight on Cardiovascular Disease: Outcomes following TAVR, LDL receptor status and diabetes risk, statin intolerance, NOAC dosing, and more.

Editor's Audio Summary by Eric D. Peterson, MD, MPH, Associate Editor, the Journal of the American Medical Association, for the March 10, 2015 issue